SatiroNakamuraDe OliveiraMD

PubMed

• mutations causing hemochromatosis: variable phenotypic expression in a pair of twins.
  Akhila Vadivelan, Sarah Zhang, Daniel N Srole, Elizabeth A Marcus, George Carvalho Neto
  Haematologica. 2024-08-01
• 3 citations
  Antiviral cellular therapy for enhancing T-cell reconstitution before or after hematopoietic stem cell transplantation (ACES): a two-arm, open label phase II intervent...
  Michael D Keller, Patrick J Hanley, Yueh-Yun Chi, Paibel Aguayo-Hiraldo, Christopher C Dvorak
  Nature Communications. 2024-04-18
• 11 citations
  Intensive care risk and long-term outcomes in pediatric allogeneic hematopoietic cell transplant recipients.
  Matt S Zinter, Ruta Brazauskas, Joelle Strom, Stella Chen, Stephanie Bo-Subait
  Blood Advances. 2024-02-27

Journal Articles

• Same sibling marrow following cord allogeneic transplantation as therapy for second relapse acute promyelocytic leukemia in a pediatric patient.  
  De Oliveira SN, Kao RL, Pham A, Smith LT, Kempert P, Moore TB., Pediatric Transplantation, 3/1/2016
• Beta-globin gene transfer to human bone marrow for sickle cell disease  
  Romero Z, Urbinati F, Geiger S, Cooper AR, Wherley J, Kaufman ML, Hollis RP, Ruiz de Assin R, Senadheera S, Sahagian A, Jin X, Gellis A, Wang X, Gjertson D, De Oliveir..., J Clin Invest, 1/1/2013
• Epidemiological evaluation of leprosy and leprosy health services in Ribeirao Preto City, Brazil, in 1992  
  Oliveira, SN; Hennemann,GV; Ferreira,FLF; Azevedo,SA; Forster, AC, Medicina, 1/1/1996

Books/Book Chapters

• Natural Killer Cells - Methods in Molecular Biology vol.1441 
  Chapter: In Vitro Generation of Human NK Cells Expressing Chimeric Antigen Receptor Through Differentiation of Gene-Modified Hematopoietic Stem Cells 
  Page 241 - 251Emily Lowe, Laurel C. Truscott, Satiro N. De OliveiraEditors: Srinivas S. Somanchi.Springer , New York2016

Abstracts/Posters

• Dissecting the Immune Cell Progeny of CAR-Expressing Hematopoietic Stem Cells in a Humanized Mouse Model
  Satiro N. De Oliveira, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
• Autologous hematopoietic stem cell gene therapy for cerebral adrenoleukodystrophy - Results of an international Phase 2/3 trial
  Satiro De Oliveira, Florian Eichler, Christine Duncan, Patricia L. Musolino, Paul J. Orchard, Adrian Thrasher, Myriam Armant, Colleen Dansereau, Troy C. Lund, Weston P..., 40th Annual Meeting of the Society for Inherited Metabolic Disorders (SIMD), San Diego, CA, 1/11/2018
• Isolated Testicular Recurrence of AML in Patients with Chronic GVHD more than One Year following Transplant.
  Dang B, Bowles LV, De Oliveira SN and Moore T, 30th Annual Meeting of the American Society of Pediatric Hematology/Oncology (ASPHO), Pediatric Blood & Cancer 64 Supplement, Montreal, Quebec, Canada, 1/26/2017
• Evaluation of Engraftment of Gene-modified Human Hematopoietic Stem Cells Using ImmunoPET
  Truscott LC, Chiou TT, Wu A and De Oliveira SN, Fourth Annual UCLA Children's Discovery and Innovation Institute Symposium, Los Angeles, CA, 1/25/2017
• Engineering Precision Medicine to Enhance Graft-Versus-Lymphoma Activity: Hematopoietic Stem Cells Modified with Chimeric Antigen Receptors
  Kao RL, Truscott LC, Chiou TT and De Oliveira SN, 59th Annual Meeting of the American Society of Hematology, Atlanta, GA, 1/8/2017
• Engineering Precision Medicine to Enhance Graft-Versus-Lymphoma Activity: Hematopoietic Stem Cells Modified with Chimeric Antigen Receptors.
  Kao RL, Truscott LC, Chiou TT and De Oliveira SN, 59th Annual Meeting of the American Society of Hematology, Atlanta, GA, 1/8/2017
• Autologous hematopoietic stem cell gene therapy for cerebral adrenoleukodystrophy - Interim results and initial long-term follow-up of an international clinical study
  Florian Eichler, Christine Duncan, Patricia L. Musolino, Paul J. Orchard, Satiro De Oliveira, Adrian Thrasher, Myriam Armant et al, 46th Annual Meeting of the Child Neurology Society, Kansas City, MO, 1/4/2017
• Gene Modification of Human Hematopoietic Stem Cells with Suicide Genes as a Safety Control System
  Truscott LC, Kao R, Chiou TT and De Oliveira SN, 2017 Pediatric Academic Societies (PAS) Annual Meeting, San Francisco, CA, 1/1/2017
• Safety and Efficacy of Gene Therapy Using a Modified Self-Inactivating Gammaretroviral Vector for SCID-X1.
  Pai S-Y, Marsh R, Kohn DB, Gaspar HB, Hacein-Bey-Abina S, Notarangelo LD, Malik P, De Oliveira S, Fischer A, Cavazzana M et al, Journal of Clinical Immunology, 1/1/2017
• Engineering Precision Medicine to Increase Graft-Versus-Lymphoma Activity: Hematopoietic Stem Cells Modified with Chimeric Antigen Receptors
  Truscott LC, Kao R, Chiou TT, Kohn DB and De Oliveira SN, 2017 Pediatric Academic Societies (PAS) Annual Meeting, San Francisco, CA, 1/1/2017
• Gene modification of human hematopoietic stem cells with suicide genes as a safety control
  Truscott LC, Rahman N, Kao RL, Chiou TT, De Oliveira SN, Science Day of the Department of Pediatrics at UCLA, Los Angeles, CA, 1/26/2016
• Gene modification of human HSC with suicide genes for clinical applications
  Rahman N, Dinoso T, Truscott LC, Chiou TT and De Oliveira SN, 2016 UCLA Research Poster Day, Los Angeles, CA, 1/24/2016
• PL02.002 - Interim Results from a Phase 2/3 Study of the Efficacy and Safety of Ex Vivo Gene Therapy With Lentiviral Vector (Lenti-D) for Childhood Cerebral Adrenoleuk...
  Eichler F, Duncan CN, Thrasher AJ, Shah AJ, Baruchel A, Paker A, Kohn DB, Bratkovic D, Shamir E, Raymond G, Gaspar B, Amartino H, Dalle JH, Larghero J, Smith NJC, Muso..., Neurology, 1/5/2016
• Gene Modification of Human Hematopoietic Stem Cells with Suicide Genes As a Safety Control.
  Truscott LC, Chiou TT, Kao RL and De Oliveira SN, 58th Annual Meeting of the American Society of Hematology, Blood, San Diego, CA, 1/3/2016
• Development of Optimized Protocol for Generation of NK Cells Expressing Chimeric Antigen Receptors from Hematopoietic Stem Cells for Cancer Immunotherapy.
  Truscott LC, Chiou TT and De Oliveira SN, Sixth Annual ImmunologyLA, Los Angeles, CA, 1/3/2016
• AntiCD19 Chimeric Antigen Receptor in Hematopoietic Stem Cells Controlled By the Suicide Gene HSVsr39TK for Immunotherapy of B-Lineage Malignancies
  Truscott LC, Chiou TT and De Oliveira SN, 58th Annual Meeting of the American Society of Hematology, San Diego, CA, 1/3/2016
• Umbilical Cord Blood (UCB) Transplantation in Children with Acute Leukemia: Impact of Conditioning Regimen on Transplant Outcomes.
  Eapen M, Kurtzberg J, Zhang M-J, Mendizabal AM, Chang KW, Duval M, Fei M, Neudorf S, De Oliveira SN, Wall DA et al, 58th Annual Meeting of the American Society of Hematology, Blood, San Diego, CA, 1/3/2016
• Development of Optimized Protocol for Generation of Natural Killer Cells Expressing Chimeric Antigen Receptors from Hematopoietic Stem Cells for Cancer Immunotherapy.
  Patel A, Truscott L and De Oliveira SN, Journal of Investigative Medicine, 1/1/2016
• AntiCD19 Chimeric Antigen Receptor in Hematopoietic Stem Cells Controlled By the Suicide Gene HSVsr39TK for Immunotherapy of B-Lineage Malignancies.
  Truscott LC, Chiou TT and De Oliveira SN, 58th Annual Meeting of the American Society of Hematology, 1/1/2016
• A Cetuximab-Mediated Suicide System for Hematopoietic Stem Cell Gene Therapy
  Kao RL, Tu A, Tyagi T and De Oliveira SN, 2nd Annual UCLA Children's Discovery and Innovation Institute Symposium: "Catalyzing and Expanding Interdisciplinary Collaboration in Translational Child Health, Los Angeles, CA, 1/28/2015
• Development of optimized protocol for generation of NK cells expressing chimeric antigen receptors from hematopoietic stem cells for cancer immunotherapy
  Patel A, Truscott L and De Oliveira SN, 57th Annual Meeting of the American Society of Hematology, Orlando, FL, 1/5/2015
• Pre-Clinical Development of Gene Modification of Hematopoietic Stem Cells with Chimeric Antigen Receptors for Cancer Immunotherapy.
  Truscott LC, Larson S, Patel A, Kao R, De Oliveira SN, 57th Annual Meeting of the American Society of Hematology, Orlando, FL, 1/5/2015
• Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency.
  Kohn DB, Shaw KL, Sokolic R, Carbonaro DA, Davila A, Barman P, Garabedian E, Silvin C, De Oliveira SN, Shah AJ, Moore TB, Hershfield M, Thrasher A, Gaspar RG, Candotti F, Biol Blood Marrow Transplant, 1/1/2015
• Development of Optimized Protocol for Generation of NK Cells Expressing Chimeric Antigen Receptors from Hematopoietic Stem Cells for Cancer Immunotherapy.
  Patel A, Truscott LC, De Oliveira SN, Blood, 1/1/2015
• Pre-Clinical Development of Gene Modification of Hematopoietic Stem Cells with Chimeric Antigen Receptors for Cancer Immunotherapy.
  Truscott LC, Larson S, Patel A, Kao RL and De Oliveira SN, Blood, 1/1/2015
• Join now to see all

Lectures

• Engineering Precision Medicine to Increase Graft-Versus-Lymphoma Activity: Hematopoietic Stem Cells Modified with Chimeric Antigen Receptors 
  2018 ASH Annual Meeting - San Diego, CA - 12/1/2018
• Humanized Mouse Models for Hematopoietic Stem Cell Research: Principles and Pitfalls 
  1/1/2018
• Treatment of Neuroblastoma with Natural Killer Cells Genetically Engineered to Target Tumor Cells 
  Los Angeles, CA - 1/1/2018
• Principles of Cancer Immunotherapy 
  Galveston, TX - 1/1/2017
• Gene Modification of Human Hematopoietic Stem Cells with Suicide Genes as a Safety Control System 
  Washington, DC - 1/1/2017
• Engineering Precision Medicine by Modification of Hematopoietic Stem Cells 
  Los Angeles, CA - 1/1/2017
• Transplantation for Autoimmunity/Immune Dysregulation - Case Presentation: 14 yo. girl with IBD and HLA-B27 AS 
  Los Angeles, CA - 1/1/2016
• Gene-modified hematopoietic stem cells for cancer immunotherapy 
  Los Angeles, CA - 1/1/2016
• Engineered cellular therapy for AIDS-associated non-Hodgkin's lymphoma 
  UCLA, Los Angeles, CA - 1/1/2016
• Persistent neutropenia in an infant after gene therapy for ADA-SCID 
  Montreal, Canada - 1/30/2015
• Gene Modification of Hematopoietic Stem Cells for Enhancement of Graft-versus-Lymphoma Effect 
  Los Angeles, CA - 1/28/2015
• Basic Principles of Tumor Immunotherapy 
  Los Angeles, CA - 1/19/2015
• Autologous Transplant/Gene Therapy for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency 
  San Diego, CA - 1/11/2015
• Cellular therapies 
  UCLA, Los Angeles, CA - 1/1/2015
• Graft Versus Host Disease 
  UCLA, Los Angeles, CA - 1/1/2015
• Introduction to the Cellular Therapies Program at UCLA 
  UCLA, Los Angeles, CA - 1/1/2015
• Cancer Immunology and Immunotherapy 
  UCLA, Los Angeles, CA - 1/1/2015
• Gene Modification of Hematopoietic Stem Cells with Chimeric Antigen Receptors 
  Arrowhead, CA - 1/1/2015
• Anti-CD19 Immunotherapy Using Gene-Modified Hematopoietic Stem Cells 
  Los Angeles, CA - 1/29/2014
• Immunotherapy of B-lineage hematological malignancies with gene-modified progenitor cells 
  Los Angeles, CA - 1/29/2014
• Second-Generation Chimeric Antigen Receptors Successfully Modify Hematopoietic Stem Cells for Immunotherapy of B-Lineage Malignancies 
  Los Angeles, CA - 1/22/2014
• Cancer Immunotherapy with Gene-Modified Hematopoietic Stem Cells 
  Los Angeles, CA - 1/17/2014
• Modification of Hematopoietic Stem Cells with CD19-Specific Chimeric Antigen Receptors as a Novel Approach for Cancer Immunotherapy 
  Denver, CO - 1/19/2013
• What are the benefits of biobank (and related) research? 
  Los Angeles, CA - 1/1/2013
• Phase II Clinical Gene Therapy Trial for Adenosine Deaminase-Deficient Severe Combined Immune Deficiency (ADA-SCID). 
  Salt Lake City, UT - 1/1/2013
• Join now to see all